Sign in

NCT06251193Active, not recruiting

Optimizing CBSST With Executive Function Training for Schizophrenia

Optimizing Cognitive Behavioral Social Skills Training With Executive Function Training for Older Adults With Schizophrenia

Source: ClinicalTrials.gov · Last updated 5 Nov 2025

Brief summary (registry, in English)

The purpose of this research study to test a blended intervention that combines Executive Function Training with Cognitive-Behavioral Skills Training (E-CBSST). The aims include determining whether E-CBSST is feasible and increases Cognitive Behavioral Social Skills Training (CBSST) Skills Learning to a level that will lead to a clinically meaningful improvement in functioning.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
49 (actual)
First submitted
22 Jan 2024
Start date
20 Mar 2024
Primary completion date
10 Feb 2026
Lead sponsor
University of California, San Diego
NCT number
NCT06251193

What you commit to

  • Study type: Interventional
  • Participants enrolled: 49
  • From 20 Mar 2024 to the primary completion date, 10 Feb 2026
  • 2 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Meets diagnostic criteria for bipolar disorder, current major depressive episode, or substance abuse or dependence within the six months prior to the baseline assessment except for caffeine or nicotine;
  • Received electroconvulsive therapy within six months of the baseline assessment.

Other illness

  • Meets criteria for a cognitive disorder or for a neurological or other medical disorder affecting the ability to participate in Executive Function Training or CBSST;

Who the study is looking for

  • Voluntary informed consent to participate;
  • Age 60 years or older;
  • DSM-5 diagnosis of schizophrenia or schizoaffective disorder based on the SCID;
  • Be clinically stable as operationalized by (1) not having been admitted to a psychiatric hospital within the three months prior to assessment, (2) having had no change in antipsychotic medication dosage within four weeks prior to the baseline assessment, and (3) and ascertained to be clinically and medically stable by one the study investigators;
  • Be willing and able to speak English;
  • Be able to read and converse (with corrected vision or hearing if needed).

Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Centre for Addiction and Mental Health
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status
UC San Diego
Coordinator of this site? Confirm its status
La JollaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.